Interestingly, a study comparing VHL and CRBN dependencies in diverse tumor types concluded that VHL-based PROTACs can induce degradation in a broader number of cell lines, as CRBN was frequently found inactivated or expressed at low levels in lung and colon cancer lines [34]. Here, CRBN is linked to neoplasm.